Successful use of a defined antigen/GM-CSF adjuvant vaccine to treat mucosal leishmaniasis refractory to antimony: a case report

Immunotherapy has been proposed as a method to treat mucosal leishmaniasis for many years, but the approach has been hampered by poor definition and variability of antigens used, and results have been inconclusive. We report here a case of antimonial-refractory mucosal leishmaniasis in a 45 year old...

Full description

Bibliographic Details
Main Authors: Roberto Badaro, Iza Lobo, Maria Nakatani, Alvaro Muiños, Eduardo M. Netto, Rhea N. Coler, Steven G. Reed
Format: Article
Language:English
Published: Elsevier
Series:Brazilian Journal of Infectious Diseases
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702001000400008&lng=en&tlng=en